Objectives. The objectives of this study were to investigate and validate individual variables and to develop a composite score for disease activity measurement in patients with reactive arthritis (REA).
Reactive arthritis (REA) is a sterile mono-or oligothe causative organism and thus to subacute or chronic arthritis. arthritis which evolves several days or weeks after an infection, usually of bacterial origin, most commonly On the basis of these events it has been postulated that therapy with antibiotics could reduce the duration involving the urogenital or gastrointestinal tract [1] . REA can be triggered, for example, by Salmonella, of the disease and prevent chronic arthritis [8] [9] [10] [11] . Although the symptoms also commonly resolve spontanYersinia, Chlamydia and Mycoplasma species [1] [2] [3] . The disease is commonly associated with HLA-B27 and has eously after weeks to months, chronic courses can occur and often necessitate more 'aggressive' therapy with a temporal relationship to the infection [1, 4] . disease-modifying anti-rheumatic drugs (DMARDs) Characteristically, and in contrast to classical infecsuch as sulphasalazine, gold compounds or methotrexate tious arthritis, the agent(s) cannot be cultured and [12, 13] . There exist only a few systematic studies on therefore, may not be 'viable' once having reached the issue of the effectiveness of these or other therapeutic the joints. However, using sensitive detection methods, approaches. This is in part due to the lack of established such as immunohistology, electron microscopy and disease activity criteria which can be followed prospectpolymerase chain reaction, evidence of the presence of ively and reliably in controlled studies. infectious agents within the joint fluid or synovial Disease activity criteria have been established for membrane has been found [5] [6] [7] .
several chronic inflammatory rheumatic diseases, includThus, it is assumed that cells (probably/likely of the ing rheumatoid arthritis (RA) and systemic lupus erythmonocyte lineage) containing infectious agents or their ematosus (SLE) [14] [15] [16] [17] . In RA, a large number of fragments gain access to the joint and induce a cellular clinical and laboratory variables have been analysed, immune response, which does not lead to rapid and and based on preliminary research on activity and complete elimination of the inciting agent, but rather to outcome indices or scores, core sets have recently been a 'smouldering' immune response with persistence of agreed upon by several international organizations [16] [17] [18] . These sets of variables intend to use a limited ical value for disease activity, such as the disease activity score, which may allow improved analysis of therapeutic performed in every patient. This included evaluation of the total joint count for swelling and tenderness. For response or progression of disease [14, 19] . the prospectively studied group, all data (clinical and More recently, a disease activity score has been laboratory evaluations) were repeated at the last control proposed for ankylosing spondylitis [20] , another examination. Clinical evaluations, including joint exam-HLA-B27-associated disease which, in contrast to REA, inations, were performed by the same assessor in each involves predominantly the spine rather than the individual patient. The assessor in the first part of the peripheral joints. study was different from the assessors in the second In order to allow for an improvement in the followpart. The assessors were physicians with at least 3 yr of up of REA patients, particularly those in whom the rheumatological experience. disease runs a chronic course, we searched for a possible
The following laboratory tests were performed: comset of variables as a first step in the development of a plete blood cell count, routine blood chemistry, erythrodisease activity score for REA. To this end, we evaluated cyte sedimentation rate ( ESR; mm/h), C-reactive protein the validity of commonly used variables for the assess-(CRP; mg/dl ), rheumatoid factor (RF ) and HLA-B27. ment of disease activity in REA by analysing these Antibody titres for Salmonella species and Yersinia variables individually in a cross-sectional study. Then, enterocolitica (immunoperoxidase assay and Gruber in a second prospective investigation of REA in patients Widal agglutination tests kindly performed by the who underwent antibiotic therapy, all these variables Institute of Hygiene of the University of Vienna) were were evaluated again individually. In addition, a commeasured. Genitourethral swab cultures (for Chlamydia posite index derived from those variables which had and Mycoplasma), antibody titres for Chlamydia (tested been found most useful as a result of the first crossby IPA Zyme Chlamydia, Savyon) and stool cultures sectional study was tested. The data obtained show the (for Yersinia enterocolitica, Salmonella, Shigella and derivation and reliability of a disease activity index for Campylobacter) were performed in each patient [22] . REA (DAREA) which is also very easy to calculate on Standard radiographs of involved joints as well as a day-to-day basis.
lumbar spine and sacroiliac joint X-rays, when low back pain was reported, were taken.
Study populations

Patients and methods
The cross-sectional study group consisted of 45 patients (14 females and 31 males) with an age range of 19-73 yr Study design and investigations (median: 37). Mean disease duration was 5.3 ± 3.3 The study was composed of two parts: first, in a crossweeks. In this group a mean of 2.0 ± 1.1 (median 2) sectional investigation the clinical and laboratory data swollen peripheral joints and a mean of 2.7 ± 1.9 from 45 consecutive REA patients were evaluated in (median 2) tender peripheral joints were involved. order to derive the variables most useful for following Recent onset low back pain was present in 17 (38%) of disease activity in REA and possibly to obtain a minimal the patients, none had early morning pain and four had set of variables suitable for the calculation of a disease pain upon examination of their sacroiliac joints. activity score. In the second part of the investigation, a Radiographic investigations did not reveal erosions in group of 23 additional patients were investigated proany of the patients' peripheral joints. In four patients spectively at two points in time, one at first presentation evidence of sacroilitis was found by conventional radioto the clinic and the other at the last follow-up visit graphy. The following joints were involved: knee joints during or immediately after therapy. in 22, ankle joints in 15, metatarsophalangeal joints in REA was defined as a sterile oligoarticular joint 11, toe interphalangeal joints in 11, metacarpophalaninflammation that developed after a distant infection geal joints in six, wrists in four, and hip joints in three originating in the urogenital or gastrointestinal tract.
patients. Synovial fluid was obtained in 12 patients; the The diagnostic management of the patients in both mean cell count was 7460 ± 3730 cells/ml. parts of the study was identical and based on internaAll patients were negative for RF by nephelometry. tional diagnostic criteria developed by consensus [21] .
HLA-B27 was positive in 60% of the patients. In particular, the presence of at least one swollen joint Genitourethral infections were diagnosed by positive for at least 2 weeks was mandatory. In addition, RA, swab cultures in 28 patients (Mycoplasma hominis ankylosing spondylitis, psoriasis, crystal arthropathies, in 22, Chlamydia trachomatis in five, both in one), an septic arthritis, and a history of inflammatory bowel additional 11 patients had a titre of anti-chlamydial disease had to be absent. Extra-articular manifestations, antibodies ≥1:16 IgA and ≥1:512 IgG (values in a history of urethritis, enteritis or cervicitis were not healthy individuals: IgA <1:16 and IgG ≤1:64; cut-off mandatory.
values: IgA: 1:16, IgG: 1:256). Genitourethral symptoms A detailed history, including that of previous infec-(burning sensations) were reported by four patients. Six tions or sexually transmitted diseases, of symptoms of patients had enterobacterial infections (three with urethritis, conjunctivitis or enteritis, but also of joint Salmonella species and three with Yersinia enterocolitica, problems and low back pain, was taken. A complete as determined by high antibody titres to these bacteria).
A history of intestinal symptoms was present in all of physical examination and laboratory investigations were these six patients. Stool cultures, however, were negative the data. For comparison between the first and the last visit in the prospective study group, the Wilcoxon test in all patients. Eye involvement (conjunctivitis) was seen in one patient.
was employed. P values <0.05 were considered significant. Data The prospective study group consisted of 23 patients (nine females and 14 males) with an age range of were processed using the SAS-program (Statistical Analysis System, Version 6.11; SAS Institute Inc, Cary, 21-65 yr (median 30). Mean disease duration was 6.1 ± 3.4 weeks. A mean of 2.5 ± 1.3 (median 2) swollen NC, USA). peripheral joints and 3.3 ± 1.7 (median 3) tender peripheral joints were involved. Recent onset low back pain Results was present in four patients (17%). None had night pain Analysis of variables in the cross-sectional study group and none had pain upon examination of their sacroiliac joints. No erosions were seen on radiographic joint
The cross-sectional analysis revealed significant correlaexaminations, and evidence for sacroilitis was not found tions between many clinical variables as well as between in any of the patients. RF was negative in all patients, many clinical variables and CRP (r up to 0.79). For the HLA-B27 was positive in 30% of the tested patients.
purpose of clarity, in Table 1 only correlations between The following joints were involved: knee joints in 12, the physician's global assessment and the different variankle joints in 12, wrist joint in four, MTP in two, ables are shown. The physician's global assessment could MCPs in two, and hip and shoulder joints each in one be exchanged for the patient's global assessment or VAS of the patients. Synovial fluid was obtained in five results without substantially changing the results (data patients; the mean cell count was 7570 ± 2370 cells/ml. not shown). The physicians' global assessment was Genitourethral infections were detected by culture in chosen for comparison because in this study, like in 16 patients (five with Mycoplasma hominis, nine with early phases of the development of other scores for Chlamydia trachomatis, and two with both), genitourwhich there is yet no gold standard for such purpose ethral symptoms (burning sensations) were reported by available, variables commonly used for the evaluation one patient. Seven patients had evidence of enterobacterof disease activity were assessed, and it is presently ial infections (five with Salmonella species, two with mostly the physician who assesses such variables and Yersinia enterocolitica, diagnosed by high antibody titres disease activity in general. to these bacteria). Five of these patients reported intest-
The following variables correlated significantly with inal symptoms (diarrhoea). The patients were investithe physician's global assessment of disease ( Table 1) : gated at first presentation and at 6 weeks after the number of swollen joints, number of tender joints, institution of antibiotic therapy. All patients received patient's pain and patient's global assessment (both by non-steroidal anti-inflammatory drugs (NSAIDs; the 3-point scale and by the VAS), low back pain and mainly diclofenac or ibuprofen). Antibiotic treatment the laboratory measures CRP, haemoglobin and leucoconsisted of tetracyclines (n = 6), macrolides (n = 11) cyte count. There was an inverse relationship with or quinolones (n = 6) in conventional doses.
haemoglobin. For reasons dealt with in detail in the discussion, the Variables selected for analysis following variables were selected to compose DAREA: The following variables were recorded for evaluation: swollen joint count, tender joint count, patient's pain number of swollen joints (usually 0-5), number of and patient's global assessment (by 3-point scale), and tender joints (usually 0-5), low back pain (absent = 0, CRP (in mg/dl ). The reason for selecting the 3-point moderate = 1, severe = 2), patient's pain assessment scale rather than the VAS was the ease with which it (0 = none, 1 = moderate, 2 = severe), patient's global can be added to the other numerical values allowing for assessment (0 = well, 1 = fair, 2 = poor), eye involveeasy and rapid calculation of the DAREA score, namely ment (none = 0, moderate = 1, severe = 2), subjective by simply adding up the numerical values obtained for symptoms of urethritis (no symptoms = 0, burning = 1, each of these five items. On this basis, in the crossdischarge = 2), intestinal symptoms (none = 0, sectional group a DAREA range of 4.0-22.5 (median diarrhoea = 1), ESR (mm/h), CRP (mg/dl ), leucocyte 10) was found, and DAREA obviously correlated very count, haemoglobin, platelet count, physician's global well (P < 0.0001) with the physician's global assessment score (on a 5-point scale, ranging from 1 = symptom- (Fig. 1A) . free, to 5 = very severe), and a 10 cm visual analogue Prospective validation of DAREA scale ( VAS, 0.0 = very well, 10.0 = worst possible) for both pain and global assessment, by the patients.
In order to validate DAREA, a prospective study of 23 patients was performed. DAREA was recorded at first Statistical evaluation presentation and after 6 weeks, i.e. during or shortly after therapy. Table 2 shows the data for each variable In both patient groups summary statistics are indicated as medians and ranges. In the cross-sectional study at the first and the last visit. Almost every single variable improved between the first and the last visit, indicating group the non-parametric Kendall correlation coefficient was used to analyse correlations between individual amelioration of the disease with time or/and therapy. DAREA amounted to a mean of 12.9 ± 5.8 at the initial variables as well as between the physician's global assessment and the disease activity score derived from visit and decreased to 2.7 ± 0.7 at the final observation (P < 0.0001). As in the cross-sectional study, the change disease: REA goes along with joint swelling and pain in joints and occasionally with involvement of the lower in the physician's global assessment and the change in DAREA were related to each other, and thus DAREA back; it is an inflammatory disorder with the respective laboratory abnormalities; and it leads to subjective was highly significantly associated with the physician's global assessment both at the beginning and at the end complaints of pain and of sickness. Of the many variables investigated, the composition of the DAREA score of the observation period (Fig. 1B) .
In several patients, DAREA was assessed not only at takes two variables assessed by the physician, two variables reported by the patient, and one laboratory two visits, but also in between. As can be seen in Fig. 2 , there was a consistent decrease of DAREA over time in variable into account. Criterion validity. A significant association was found most of the eight patients, although in two of them DAREA remained high, indicating failure to remit.
between DAREA and the physician's global assessment, which is currently the major means to assess disease Stratification according to joint counts activity. Moreover, remission is the most important response in REA. Patients in remission (as judged by When prospectively studied patients were stratified into two groups, one with one or two joints (n = 8), the the treating physician) had a normal DAREA, while the index was high in the initial phases when the disease other with three or more joints involved (n = 15), the following results were obtained: patients with one or was most active. Construct validity. The improvement of DAREA, if two involved joints had an initial mean DAREA of 8.2 ± 4.8 (range 2-18) which fell to 2.9 ± 2.9 (range obtained at several points in time in patients going into remission, was highly significant (Figs 1B, 2) . In con-0-8) at the last visit. Patients with three or more swollen joints started with a DAREA of 15.4 ± 4.6 (range 9-25) trast, patients not going into remission continued to present with a high DAREA score (Fig. 2) . and had a DAREA of 2.5 ± 3.0 (range 0-8) at the last visit. Thus, in both subgroups DAREA fell significantly over time and discriminated well between active and Discussion inactive disease.
In this study we have developed and validated DAREA, which is reliable and easy to calculate. In general, disease Actual example for calculating DAREA activity scores can be helpful both for clinical studies A patient was found to have his left knee joint, his IP and day-to-day patient care. In clinical practice the of the right third toe and his right MTP II swollen judgement of disease activity varies considerably (score 3); these joints and right MTP IV were tender between different (and even within individual ) rheum-(score 4); the patient assessed his global status as being atologists [23, 24] . Thus, the use of composite indices 2 and his pain status as 3 (very painful, because he can has been proposed (particularly for study purposes) to hardly walk despite NSAID therapy); his CRP assess disease activity based on subjective and objective amounted to 4.2 mg/dl. Thus, the total DAREA was:
criteria [23] . However, in day-to-day patient care disease 3 + 4 + 2 + 3 + 4.2 = 16.2. activity scores are rarely calculated due to time constraints, and rather than scoring disease activity, an Evaluation of validity Face validity/content validity. Each variable chosen, opinion of disease activity is usually abstracted rapidly by the physician from a combination of information. be it clinical or laboratory, can be affected by the most accurately, a cross-sectional study of variables employed to judge disease activity was performed and the results obtained used for further evaluation. The physician's global score was chosen as the main parameter for the comparisons, since there is no other 'gold standard' available and since it is the physician who currently usually 'judges' disease activity. However, no different results would have been obtained if patientderived variables had been used (data not shown).
The excellent correlation between the physician's global assessment and the other variables as well as the DAREA score could lead to the conclusion that it would be sufficient to just have the physician (or the patient) judge disease activity. However, a disease activity score should also allow less-experienced physicians to assess disease activity in REA and reach similar conclusions as experienced ones. Furthermore, DAREA should help in the evaluation of patients who judge their disease differently due to psychological or cultural factors. Finally, inaccuracies in scores of individual variables are smoothed out by combining several variables which have different sources, such as the patient, the physician, and the laboratory, as long as they correlate with the response. The best response, i.e. remission, is indicated by a normal DAREA (<1). Although DAREA, for obvious reasons, differed between patients with one or two and those with more inflamed joints, it discriminated well between active and inactive disease even in those with only a few involved joints.
The five components of DAREA are: number of swollen joints, number of tender joints, patient's pain and global assessments, and CRP (mg/dl ).
The inclusion of joint abnormalities is obvious, since arthritis is what we deal with. However, the inclusion of both swollen and tender joints is based upon the observation that tenderness often lasts longer than swelling in many forms of arthritis, which is particularly true for REA. In fact, joint tenderness correlated to a higher degree with the physician's global assessment and other variables than swelling. However, since synovitis is the major pathological process in REA, swelling was also occurred in only about a third of the patients and had
Note that a total number of 45 patients was analysed and that a lower degree of association compared with the other therefore individual points may reflect more than one patient.
variables. This is in accordance with published observa-(B) Correlation of DAREA vs physician's global assessment tions [21] and may not be surprising, since REA involves in the prospective study group at the first visit before therapy primarily the peripheral joints and usually only concur-(diamonds) and at the last visit during or after therapy (trirently, but much less commonly, also the joints of the angles). There was excellent correlation for both points in time axial skeleton; vice versa, in ankylosing spondylitis the as well as for the total analysis (P < 0.0001).
peripheral joints are affected secondarily and only infrequently.
Conjunctivitis was not taken into account, since it Therefore, the attempt of this study was not only to search for a disease activity score where there is hitherto was extremely rare, can also occur in the absence of joint disease and may subside when REA is still highly none available, but also to allow easy handling of such a score for the practising clinician. Nevertheless, as with active. Symptoms of urethritis or enteritis were also not accounted for, since they were only seen in a few patients all other disease activity scores, this one should undergo further validation in other centres and/or in consensus and in most were not present at the time of onset of arthritis. finding study groups [17] [18] [19] 25] .
To determine which factors would be best combined The inclusion of patients' assessments, although they are subjective, is important, since these variables reflect to produce a score which reflected the disease activity the most dynamic direct measures of the acute phase response and studies have shown that CRP is more responsive to tissue injury in comparison with ESR [26 ] . Moreover, as a protein induced by the action of proinflammatory cytokines, CRP responds very rapidly to the influence of inhibitors of such cytokines and much faster than ESR. However, CRP was used in mg/dl rather than g/l in order to prevent an overweight of this laboratory measure in the overall score. Haemoglobin and leucocyte counts (although also correlating well with the physician's global assessment) were not included into the final score for two reasons: (i) certain therapeutic measures, such as NSAIDs or glucocorticoids (which are used occasionally in REA) can lead to 'false' changes due to toxicity or other unwanted effects (NSAIDs by inducing gastrointestinal blood loss, and glucocorticoids by inducing leucocytosis); (ii) in contrast to the above five variables, haemoglobin and leucocytosis do not constitute part of the established disease activity indices for RA [24] and VAS for patients' assessments were based on several grounds: (i) all these variables correlated very well with disease activity and quality of life. Two 3-point scales the physician's global assessment and with each other and two 10 cm VAS were used for these assessments.
and could therefore be used in an interchanging way; All four scales correlated very well with the physician's (ii) we wished to obtain an index whose components global assessment. For the latter, a 5-point scale was should bear similar weights, whilst the use of two VAS chosen to allow more subtle discrimination of the impact scales each potentially amounting to 10 cm or 100 mm of the other variables which were compared and related would put an overweight on patients' assessments; and to the physician's global assessment.
(iii) we wished to obtain a score which could be calcuOnly one laboratory variable (CRP) was included, lated as easily as possible by the physician and be used since rheumatologists are routinely guided more by joint also at the office level without time constraints. symptoms and patients' well-being than by laboratory A simple numerical addition of the individual values abnormalities. CRP was used as a well-investigated, allows a DAREA score to be obtained which reflects reproducible marker of the acute phase response, usually disease activity. This score has face, content, criterion and construct validity and showed reasonable discriminnot affected by drug toxicity, gender or age. It is one of ant power. In particular, a complete remission was
